|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM281354316 |
003 |
DE-627 |
005 |
20231225031435.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2018 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2018.02.009
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0937.xml
|
035 |
|
|
|a (DE-627)NLM281354316
|
035 |
|
|
|a (NLM)29477343
|
035 |
|
|
|a (PII)S1521-6616(17)30333-9
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Liu, Long
|e verfasserin
|4 aut
|
245 |
1 |
2 |
|a T cell exhaustion characterized by compromised MHC class I and II restricted cytotoxic activity associates with acute B lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation
|
264 |
|
1 |
|c 2018
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 01.07.2019
|
500 |
|
|
|a Date Revised 10.12.2019
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2018 Elsevier Inc. All rights reserved.
|
520 |
|
|
|a Acute B lymphoblastic leukemia (B-ALL) relapse contributes predominantly to the mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, the mechanism of B-ALL relapse after allo-HSCT remains unknown. The eradication of leukemia after allo-HSCT largely relies on graft-versus-leukemia (GVL) effects mediated by donor T cells. T cell exhaustion, characterized by the increased expression of inhibitory receptors and impaired function, may suppress GVL effects. In this study, we evaluated whether T cell exhaustion was involved in B-ALL relapse after allo-HSCT. The results showed that CD4+ and CD8+ T cells exhibited increased coexpression of PD-1 and Tim-3, and compromised proliferative capacity, cytokine production and cytotoxic potentials in relapsed patients. Additionally, T cells at the tumor site were more easily exhausted than T cells in the peripheral blood. Moreover, the reversal of T cell exhaustion might correlate with effective anti-leukemic responses after reinduction. These results suggested that T cell exhaustion was associated with B-ALL relapse after allo-HSCT as well as its treatment outcome
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a Acute B lymphoblastic leukemia
|
650 |
|
4 |
|a Allogeneic hematopoietic stem cell transplantation
|
650 |
|
4 |
|a Relapse
|
650 |
|
4 |
|a T cell exhaustion
|
650 |
|
7 |
|a HAVCR2 protein, human
|2 NLM
|
650 |
|
7 |
|a Hepatitis A Virus Cellular Receptor 2
|2 NLM
|
650 |
|
7 |
|a Histocompatibility Antigens Class I
|2 NLM
|
650 |
|
7 |
|a Histocompatibility Antigens Class II
|2 NLM
|
650 |
|
7 |
|a Programmed Cell Death 1 Receptor
|2 NLM
|
700 |
1 |
|
|a Chang, Ying-Jun
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Xu, Lan-Ping
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhang, Xiao-Hui
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wang, Yu
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Liu, Kai-Yan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Huang, Xiao-Jun
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 190(2018) vom: 15. Mai, Seite 32-40
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:190
|g year:2018
|g day:15
|g month:05
|g pages:32-40
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2018.02.009
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 190
|j 2018
|b 15
|c 05
|h 32-40
|